Dr. Mark J. Zylka's research lab focuses on understanding the link between environmental chemicals and neurodevelopmental disorders such as autism. The lab employs advanced genome editing techniques to explore both the environmental and genetic factors that contribute to these conditions. They aim to identify harmful chemicals and develop innovative gene therapies to treat disorders like Angelman syndrome.

Dr. Yen-Yu Ian Shih's lab focuses on developing innovative imaging technologies to study brain function in mice. Specifically, they are working on a new fMRI technique called SORDINO, which aims to improve the sensitivity and specificity of imaging by tackling common issues found in traditional methods. Their research hopes to enhance our understanding of large-scale brain networks and has implications for public health by contributing new insights into brain-related disorders.

Dr. Michael C. Bressan's lab at the University of North Carolina Chapel Hill focuses on understanding the cardiac pacemaker cells, which are crucial for initiating heartbeats. The lab investigates how these cells interact with their environment and support cells to maintain their function. By exploring the mechanical and chemical factors that impact pacemaker cell health, the research aims to develop new therapies for heart conditions and improve artificial pacemaker technologies.

Dr. Bryan L. Roth's lab focuses on understanding how psychoactive drugs, like LSD, interact with specific receptors in the brain that are crucial for treating mental disorders. They use advanced techniques to study the structures of serotonin and Mas-related receptors to uncover how these drugs work at a molecular level. This research aims to improve drug design for conditions such as schizophrenia and chronic pain, leading to safer and more effective treatments.

The Love Lab focuses on developing innovative computational tools for analyzing long-read RNA sequencing data. Their work aims to create user-friendly pipelines that enhance the accuracy and interpretability of RNA sequencing results, making it easier for researchers to study gene expression and its implications in human health and disease. They also provide workshops and tutorials to help biologists and analysts use these tools effectively.

Dr. Adam Hantman's lab at UNC Chapel Hill focuses on understanding how changes in a specific gene called UBE3A affect movement control in disorders like Angelman syndrome and Dup15q syndrome. The lab uses mouse models to explore how UBE3A misexpression alters brain circuit dynamics and motor skills. Ultimately, the research aims to develop new gene therapy approaches to improve motor function in affected individuals.

Dr. Sergei Sheiko's lab focuses on developing innovative materials for breast reconstruction surgery, aiming to create a new injectable platform that mimics the natural properties of human tissue. This technology seeks to reduce the health risks associated with current implants, improve the safety and aesthetic outcomes for patients, and ultimately enhance the quality of life for those affected by breast cancer. The lab's work also opens doors for advancements in other reconstructive surgeries.

Dr. Paul Dayton's lab focuses on developing advanced ultrasound imaging technologies that can provide high-resolution images of blood vessels, particularly in relation to cancer detection. The lab has created unique devices that allow for improved visualization of microvascular structures, which are crucial for identifying cancerous tissues. Their innovative approach aims to make these imaging techniques applicable to clinical settings, providing better tools for early cancer diagnosis.

Dr. Caterina Gallippi's lab at the University of North Carolina Chapel Hill focuses on developing advanced ultrasound technologies to improve the diagnosis and monitoring of serious health conditions. Their research aims to enhance breast cancer detection through a novel ultrasound method that assesses collagen organization in breast tissue and to monitor kidney transplant rejection without invasive procedures. By combining innovative imaging techniques with biomedical engineering, her lab addresses critical gaps in patient care and disease management.

Craig E. Cameron's lab at the University of North Carolina focuses on understanding how certain viruses, particularly coronaviruses and non-polio enteroviruses, replicate their genomes and assemble themselves within host cells. By studying the enzymes involved in these processes, particularly the 2C protein of enteroviruses and the replisome of coronaviruses, the lab aims to discover new antiviral therapies and improve our understanding of viral infections. Their research has significant implications for public health, especially in combating emerging viral threats.

Dr. Deborah J Jones' lab at the University of North Carolina Chapel Hill focuses on enhancing mental health and well-being in the workplace through resilience training. Their current research is centered around a web-based resilience program designed specifically for childcare providers, highlighting its potential effectiveness in supporting essential workers. By conducting a cluster-randomized controlled trial, the lab aims to rigorously evaluate this innovative remote intervention and its impact on mental health outcomes.

Pew-Thian Yap's research lab focuses on understanding early brain development and improving MRI technology. They work on analyzing MRI data from infants to chart brain growth and investigate how structural changes relate to cognitive skills like language and motor function. Additionally, the lab is developing advanced imaging techniques to make MRI faster and more accurate, which could enhance diagnoses and treatment monitoring in clinical settings.

Dr. Baiming Zou's lab focuses on using advanced machine learning techniques to analyze complex health data, particularly related to heart, lung, blood, and sleep disorders. By addressing the challenges of heterogeneous patient populations and intricate disease interactions, the lab aims to uncover deeper causal relationships and improve individual health outcomes through tailored interventions. Their work combines statistical modeling with robust data analysis to inform better healthcare strategies.